Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis. uri icon

authors

  • Saba, Nabil F
  • Remick, Jill
  • Bates, James E
  • McDonald, Mark W
  • Rudra, Soumon F
  • Stokes, William A
  • Biernacki, Maria
  • Song, Xiaofei
  • Slebos, Robbert J C
  • Liu, Yuan
  • Steuer, Conor E
  • Chaudhary, Ritu
  • Shin, Dong M
  • Teng, Yong
  • Chung, Christine H
  • Kirtane, Kedar
  • Marra, Angelo
  • Ekpenyong, Asari
  • McCook-Veal, Ashley
  • Nicole C. Schmitt, MD
  • Gross, Jennifer H
  • Patel, Mihir R

publication date

  • August 21, 2024